REQUEST A DEMO
Total
USD $0.00
Search more companies

Great Novel Therapeutics Biotech & Medic (华上生技医药股份有限公司) (Taiwan, China)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Full name: Great Novel Therapeutics Biotech & Medic Profile Updated: June 11, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Chinese Download a sample report

Great Novel Therapeutics Biotech & Medic (华上生技医药股份有限公司) is a company in Taiwan, China, with a head office in Taipei City. It operates in the Research and Development in Biotechnology (except Nanobiotechnology) sector. The enterprise was incorporated on April 03, 2013. 22 (2025) employees currently work for Great Novel Therapeutics Biotech & Medic (华上生技医药股份有限公司). From the latest financial highlights, Great Novel Therapeutics Biotech & Medic (华上生技医药股份有限公司) reported a net sales revenue drop of 28.49% in 2025. Its’ total assets recorded a negative growth of 20.5%. Great Novel Therapeutics Biotech & Medic (华上生技医药股份有限公司)’s net profit margin decreased by 1862.11% in 2025.

Headquarters
16F.-5, No. 508, Sec. 7, Zhongxiao E. Rd.,Nangang Dist
Taipei City; Taipei City;

Contact Details: Purchase the Great Novel Therapeutics Biotech & Medic (华上生技医药股份有限公司) report to view the information.

Basic Information
Total Employees:
Purchase the Great Novel Therapeutics Biotech & Medic (华上生技医药股份有限公司) report to view the information.
Outstanding Shares:
Purchase the Great Novel Therapeutics Biotech & Medic (华上生技医药股份有限公司) report to view the information.
Financial Auditors:
Purchase the Great Novel Therapeutics Biotech & Medic (华上生技医药股份有限公司) report to view the information.
Incorporation Date:
April 03, 2013
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Vice President
Ownership Details
Purchase this report to view the information.
3.86%
Purchase this report to view the information.
2.41%
Purchase this report to view the information.
2.38%
Purchase this report to view the information.
2.3%
Purchase this report to view the information.
1.62%
Subsidiaries
Great Novel Therapeutics Biotech & Medic
1.59%
Company Performance
Financial values in the chart are available after Great Novel Therapeutics Biotech & Medic (华上生技医药股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
-28.49%
Total Operating Revenue
-28%
Operating Profit
7.41%
EBITDA
13.11%
Net Profit/Loss for the Period
7.1%
Total Assets
-20.5%
Total Equity
-20.58%
Operating Profit Margin
-1970.15%
Net Profit Margin
-1862.11%
Return on Equity (ROE)
-2.81%
Debt / Equity
-0.09%
Quick Ratio
-3.56%
Cash Ratio
-5.57%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?